Nepali
IMPACT TB
Tuberculosis kills 5,000 people every day and over 1,000 people fall sick with TB each hour. The great majority of these are the poorest members of our society, with limited access to healthcare and no resources to cope with illness. We know that for any infectious disease the best way to control epidemics is either through vaccines or finding and treating every case to prevent transmission. The only TB vaccine, BCG, is not very effective and this has allowed TB to continue to kill millions of people every year. IMPACT TB is a project to find and treat cases of…
read moreNEWS UPDATES
NEW publication from Olivia Biermann of IMPACT TB!
Posted on: June 03, 2020
We are delighted to announce the latest IMPACT TB publication from lead author Olivia Biermann and her colleagues at Karolinska Institutet: ‘Power plays plus push’: experts’ insights into the development and implementation of active tuberculosis… Read More
First national TB prevalence survey in Nepal published
Posted on: May 13, 2020
The first ever national TB prevalence survey in Nepal has revealed a very high burden of TB. The new estimates are 245/100,000 for incidence and 416/100,000 for prevalence. A staggering 40,000 TB cases go undiagnosed or… Read More
Gabriela Gomes takes up new role at prestigious university
Posted on: May 05, 2020
Our Heartiest Congratulations to our modeling lead Gabriela Gomes on her appointment to a chair at University of Strathclyde. Congratulations Professor Gomes! She has been at the Liverpool School of Tropical Medicine since 2015 and has… Read More
Our Team
Maxine Caws
(Liverpool School of Tropical Medicine)
Max Caws is the Principal Investigator of IMPACT TB and a senior TB researcher at the Liverpool School of Tropical Medicine. She was Head of the TB group at Oxford University Clinical Research Unit Vietnam for 11 years and researches diverse aspects of TB including drug resistance, diagnosis, clinical treatment trials, bacterial virulence and host susceptibility determinants. She is currently based in Kathmandu, Nepal. She has a BSc in biochemistry from the University of St Andrews, a PHD in medical microbiology from King’s College, London, where her thesis topic was tuberculous meningitis, and an MSC in epidemiology from the London School of Hygiene and Tropical…
Bertie Squire
(Liverpool School of Tropical Medicine)
Bertie Squire is leading the health economics assessment of IMPACT TB. Bertie studied medicine and immunology at University College London and Cambridge University before professional training in internal medicine, infectious diseases and respiratory medicine at the Royal London Hospital and the Royal Free Hospital. From 1992 to 1995 he was Head of the Department of Medicine, Kamuzu Central Hospital, Lilongwe, Malawi. Since his appointment at LSTM in 1995, Bertie has maintained his research collaboration with the National TB Control Programme in Malawi and has facilitated the transformation of the collaboration into the Malawi-registered Trust for Research on Equity And Community Health (REACH). With his colleagues…
Gabriela Gomes
(Liverpool School of Tropical Medicine)
Gabriela Gomes is leading the transmission modelling component of IMPACT TB. Gabriela Gomes graduated in Applied Mathematics from the University of Porto in 1987, and completed her MSc and PhD in Mathematics from the University of Warwick in 1990 and 1993, respectively. In 1999, she was awarded a Wellcome Research Training Fellowship in Mathematical Biology. In 2002, she established her independent group at the Gulbenkian Science Institute, in Portugal, initially supported by a Marie Curie Excellence Grant, with a spectrum of projects ranging from fundamental mathematical concepts to management of population and ecosystem health, public engagement in science and development of research infrastructures. Since 2015,…